Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jennifer S. Romer-Seibert"'
Autor:
Sara E. Meyer, Neil Palmisiano, Olga A. Guryanova, Yang Feng, Melanie L. Goetz, Amanda M. Versace, Michael E. Lawler, Jennifer S. Romer-Seibert, Holly A. Gamlen
Supplementary Table from miR-196b–TLR7/8 Signaling Axis Regulates Innate Immune Signaling and Myeloid Maturation in DNMT3A-Mutant AML
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0821965e18833f4f08c1036fffb10de0
https://doi.org/10.1158/1078-0432.22488596
https://doi.org/10.1158/1078-0432.22488596
Autor:
Sara E. Meyer, Neil Palmisiano, Olga A. Guryanova, Yang Feng, Melanie L. Goetz, Amanda M. Versace, Michael E. Lawler, Jennifer S. Romer-Seibert, Holly A. Gamlen
Purpose:DNMT3A mutations confer a poor prognosis in acute myeloid leukemia (AML), but the molecular mechanisms downstream of DNMT3A mutations in disease pathogenesis are not completely understood, limiting targeted therapeutic options. The role of mi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::993613966e063e2a58adec2b0f7eaffc
https://doi.org/10.1158/1078-0432.c.6532769.v1
https://doi.org/10.1158/1078-0432.c.6532769.v1
Autor:
Sara E. Meyer, Neil Palmisiano, Olga A. Guryanova, Yang Feng, Melanie L. Goetz, Amanda M. Versace, Michael E. Lawler, Jennifer S. Romer-Seibert, Holly A. Gamlen
Supplementary Data from miR-196b–TLR7/8 Signaling Axis Regulates Innate Immune Signaling and Myeloid Maturation in DNMT3A-Mutant AML
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f25b6855634ff24a733b6fc5e7a973e
https://doi.org/10.1158/1078-0432.22488611.v1
https://doi.org/10.1158/1078-0432.22488611.v1
Autor:
Holly A. Gamlen, Jennifer S. Romer-Seibert, Michael E. Lawler, Amanda M. Versace, Melanie L. Goetz, Yang Feng, Olga A. Guryanova, Neil Palmisiano, Sara E. Meyer
Publikováno v:
Clin Cancer Res
Purpose: DNMT3A mutations confer a poor prognosis in acute myeloid leukemia (AML), but the molecular mechanisms downstream of DNMT3A mutations in disease pathogenesis are not completely understood, limiting targeted therapeutic options. The role of m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c23de80034d84915edd5654c5bf4d8d0
https://pubmed.ncbi.nlm.nih.gov/35943291
https://pubmed.ncbi.nlm.nih.gov/35943291
Autor:
Sara E Meyer, Jennifer S Romer-Seibert
Publikováno v:
Curr Opin Hematol
PURPOSE OF THE REVIEW: Clonal heterogeneity is a significant obstacle to successful treatment of patients with acute myeloid leukemia (AML). Here we review new advances in the understanding of genetic heterogeneity in AML using single cell DNA sequen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0d3ed5729541b0c523d3050171f192d
https://doi.org/10.1097/moh.0000000000000626
https://doi.org/10.1097/moh.0000000000000626